Predictive Value of CD229, CD319 and c-Maf Overexpression for Treatment Response in Multiple Myeloma Patients

Prognostic Value of Interleukin-17 A Gene Polymorphism and Serum IL-17 Levels in Adult Acute Myeloid Leukaemia Patients

Assessment of the Serum Level of Interleukin-6 and Interleukin-10 in Newly Diagnosed Acute Myeloid Leukemia Patients and the Response to Induction Chemotherapy

Interleukin-10 -1082 A/G Promoter Polymorphism in Newly Diagnosed Gastro-Intestinal Malignancies and Its Relation to the Nutritional and Performance Status

Role of CD319 Expression as A Diagnostic and Prognostic Marker in Plasma Cell Myeloma Patients

Prognostic Value of CD56 Expression in Multiple Myeloma

PROGNOSTIC IMPLICATIONS OF ENDOTHELIAL ACTIVATION AND STRESS INDEX (EASIX) IN MULTIPLE MYELOMA PATIENTS

The Prognostic Significance of Baseline Serum Ferritin in Patients with Non-Hodgkin Lymphomas: A Prospective Single-Institution Study

Study of The Role of Soluble Mannose Receptor (sMR/sCD206) in Multiple Myeloma

Impact of CRAB Criteria on The Prognosis of Patients with Multiple Myeloma Compared to Other Prognostic Factors in The Era of Novel Agents